RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Background: The aim of this study was to determine the survival rate of patients with non-small cell lung cancer (NSCLC) who were preoperatively diagnosed with a negative N2 lymph node, but postoperatively confirmed as a positive N2 node based on a pathological evaluation. Materials and Methods: The hospital records of 248 patients from 1994 to 2009 with resected primary NSCLC who were preoperatively diagnosed with negative N2 lymph node, were retrospectively reviewed. Of these, after surgery, there were 148 (59.7%) patients with pathological N0, 54 (21.8%) with pathological N1 and 46 (18.5%) with pathological N2. Results: The median follow-up period was 24 months (range, 1 to 132 months). The 5-year disease free survival rates were 60% in pN0, 44% in pN1, and 29% in pN2. The 5-year overall survival rates were 63.1% in pN0, 51.9% in pN1, and 33.5% in pN2. There were no statistically significant differences between pN1 and pN2 (p=0.326 and p=0.106, respectively). Thirty-three (71.7%) of the 46 pN2 patients had single-zone metastasis, and 13 patients (28.3%) had multiple-zone metastases over the two nodal zone metastasis. There were no statistical differences in the 5-year disease free survival rate and the 5-year overall survival rates between the two groups. Conclusion: The 5-year disease free survival and the overall survival rate of the patients with unsuspected N2 disease were statistically similar with that of the patients with pathological N1 disease. There was no statistically significant difference between the patients with a single-zone metastasis and a multiple zone metastasis.

참고문헌 (Reference)

1 김대준, "절제된 IIIA N2 병기 비소세포형 폐암에 있어서 Nodal Station의 의의" 대한흉부외과학회 36 (36): 489-496, 2003

2 Nakagiri T, "Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer" 12 : 733-738, 2011

3 Naruke T, "The spread of lung cancer and its relevance to surgery" 68 : 1607-1621, 1967

4 Misthos P, "The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer" 86 : 1626-1630, 2008

5 Kang CH, "The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer" 86 : 1092-1097, 2008

6 Rusch VW, "The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer" 4 : 568-577, 2009

7 Cerfolio RJ, "Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer" 86 : 362-366, 2008

8 De Leyn P, "Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease)" 10 : 649-654, 1996

9 Fukui T, "Significance of the number of positive lymph nodes in resected non-small cell lung cancer" 1 : 120-125, 2006

10 Inoue M, "Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe" 127 : 1100-1106, 2004